跳至主要内容
临床试验/NCT00309426
NCT00309426Unknown不适用

The Effect of Serum Fetuin A Concentration on the 5-Year Prognosis in Hemodialysis Patients

University of Shizuoka1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2001年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
试验地点
1

研究概览

简要总结

The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.

详细描述

Fetuin A is known to be a potent inhibitor of ectopic calcification in plasma, and the concentration of fetuin A is closely associated with protein nutritional status. The purpose of this study is to examine whether the plasma concentration of fetuin A is associated with atherosclerosis and 5-year prognosis in hemodialysis patients.

研究设计

研究类型
Observational
观察模型
Defined Population
时间视角
Other

入排标准

年龄范围
0 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hemodialysis for at least 6 months

排除标准

  • Disabled patients

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Effect of Fetuin A in Hemodialysis Patients | 临床试验